Table 4.
Prevalence of each disease chapter and its associations with the periodontal status.
| Disease Chapters | Severe Periodontal Disease n (%) |
Severe Periodontal Disease OR (95% CI) |
Total Periodontal Disease n (%) |
Total Periodontal Disease OR (95% CI) |
|---|---|---|---|---|
| Cardiovascular diseases (n = 135) | 30 (22.2) | 2.33 (1.25 to 4.33) | 82 (60.7) | 1.61 (1.04 to 2.50) |
| Nutritional and metabolic diseases (n = 111) | 21 (18.9) | 1.25 (0.66 to 2.35) | 59 (53.2) | 0.97 (0.62 to 1.53) |
| Endocrine systemic diseases (n = 84) | 15 (17.9) | 1.14 (0.57 to 2.27) | 45 (53.6) | 1.00 (0.61 to1.63) |
| Viruses (n = 40) | 5 (12.5) | 0.73 (0.26 to 2.65) | 21 (52.5) | 0.95 (0.49 to 1.84) |
| Nervous system diseases (n = 36) | 4 (11.1) | 0.80 (0.25 to 2.55) | 22 (61.1) | 1.41 (0.70 to 2.85) |
| Digestive system diseases (n = 36) | 5 (13.9) | 0.95 (0.33 to 2.74) | 21 (58.3) | 1.24 (0.62 to 2.49) |
| Hemic and lymphatic diseases (n = 35) | 4 (11.4) | 0.51 (0.11 to 1.55) | 14 (40.0) | 0.54 (0.27 to 1.11) |
| Neoplasm (n = 28) | 5 (17.9) | 1.02 (0.35 to 2.98) | 14 (50.0) | 0.85 (0.39 to 1.85) |
| Musculoskeletal diseases (n = 24) | 12 (12.5) | 0.70 (0.19 to 2.57) | 12 (50.0) | 0.86 (0.37 to 1.96) |
| Respiratory tract diseases (n = 18) | 3 (16.7) | 0.76 (0.21 to 2.85) | 7 (38.9) | 0.53 (0.20 to 1.41) |
| Urogenital diseases (n = 19) | 4 (21.0) | 1.29 (0.38 to 4.37) | 10 (52.6) | 0.96 (0.38 to 2.42) |
| Skin and connective tissue diseases (n = 16) | 1 (6.3) | 0.35 (0.04 to 2.83) | 8 (50.0) | 0.86 (0.32 to 2.34) |
| Mental disorders (n = 11) | 0 (0.0) | 0.73 (0.67 to 0.80) | 5 (45.5) | 0.71 (0.21 to 2.38) |
| Immune system diseases (n = 8) | 0 (0.0) | 0.56 (0.06 to 4.93) | 0 (0.0) | 0.51 (0.12 to 2.17) |
| Development anomalies (n = 2) | N/A | N/A | N/A | N/A |
| Eye diseases (n = 1) | N/A | N/A | N/A | N/A |
| Infections (n = 1) | N/A | N/A | N/A | N/A |
Values represent n (%) or odds ratios (OR) and corresponding 95% confidence intervals (CI); N/A, not applicable. Note, values for n (%) add up to higher numbers than the total study population due to multimorbidity.